Article

Soft contact lenses do not hasten myopia in children

Soft contact lens wear does not accelerate the development of myopia in children, a new study shows.

Fort Lauderdale, FL-Soft contact lens wear does not accelerate the development of myopia in children, a new study shows. Findings from the 3-year study were presented recently at the annual meeting of the Association for Research in Vision and Ophthalmology.

According to the multi-site trial, no clinically meaningful difference exists between spectacles and contact lenses for treating nearsightedness in children. The new research further dispels a belief that soft contact lenses increase myopia progression more than other vision correction options.

"Children as young as 8 years old who require vision correction are capable of contact lens wear, and this study confirms that they can safely be fitted in soft contact lenses to correct their myopia," said Jeffrey J. Walline, OD, PhD, Ohio State University College of Optometry, Columbus, and leader of the Adolescent and Child Health Initiative to Encourage Vision Empowerment, or ACHIEVE, Study, of which this research was a part.

The purpose of this study was to measure refractive error, corneal curvature, and axial length of children aged 8 to 11 years randomly assigned to wear single-vision glasses (n = 237) or soft contact lenses (n = 247) for 3 years to compare the rate of myopic progression with each mode of correction over the 3-year period. A total of 484 myopic children participated in the single-masked trial conducted from September 2003 to October 2007 at five clinical centers in the United States.

Measurements were conducted prior to randomization and annually. Nearly all (467 or 96.5%) of the subjects were examined at the final visit. Myopia in the spectacle-wearers progressed –1.08 ± 0.71 D, and in the contact lens wearers myopia progressed –1.27 ± 0.72 D (analysis of covariance, p = 0.005); although that difference is statistically significant, the difference is less than can be clinically measured. The axial growth was 0.59 ± 0.37 mm for the spectacle-wearers and 0.63 ± 0.34 mm for the contact lens wearers (analysis of covariance, p = 0.27). The change in the steep corneal meridian was 0.05 ± 0.69 D for the spectacle wearers and 0.10 ± 0.70 D for the contact lens wearers (analysis of covariance, p = 0.43). Those differences were not statistically significant.

The study was supported by funding from Vistakon, a division of Johnson & Johnson Vision Care Inc.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.